First RayStation® order in China

RaySearch Laboratories AB received regulatory market approval in July by the
Chinese regulatory agency CFDA for RaySearch’s treatment planning system
RayStation® and today RaySearch received the first RayStation® order on the
Chinese market. The order was received from Ganzhou People’s Hospital in
Ganzhou, Jiangxi Province, China.

Ganzhou People’s Hospital will use RayStation® for treatment planning of both
conventional treatments and IMRT. The order also includes advanced tools
enabling a more efficient treatment planning process, such as Multi-Criteria
Optimization (MCO). This highly intuitive tool lets the clinician evaluate the
impact of changing different treatment priorities in real-time, which has a
large potential to speed up the time-consuming treatment planning optimization
process.

“RayStation® helps us solve complicated tumor cases and increase the speed of
the physicists’ tasks. Especially MCO is an excellent module that speeds up the
clinical process”, says Director Deng from Ganzhou People’s Hospital.

Frank Qian, President of the regional distributor Beijing KangLiDa Trading Corp.
that is responsible for marketing, sales and service of RayStation® on the
Chinese market, adds: ”The cancer treatment technology in China needs to evolve
fast and RayStation® contains a lot of unique advanced tools that meet the
technology development needs on the Chinese market. With its excellent
development team I believe RaySearch will remain in the forefront in the field
of radiation treatment planning.”

“China is one of the largest radiation therapy markets in the world today and it
has perhaps the largest growth potential of all markets. This means that we are
of course happy to receive our first order so quickly after securing regulatory
approval. Kang Li Da is in the final stages of negotiations with several other
clinics as well so we have high hopes for this market for the remainder of the
year”, says Johan Löf, CEO of RaySearch.


About RayStation®
RayStation® integrates all RaySearch’s advanced treatment planning solutions
into a flexible treatment planning system. It combines unique features such as
multi-criteria optimization tools with full support for 4D adaptive radiation
therapy. It also includes functionality such as RaySearch’s market-leading
algorithms for IMRT and VMAT optimization and highly accurate dose engines for
photon, electron and proton therapy. The system is built on the latest software
architecture and has a graphical user interface offering state-of-the-art
usability.

About RaySearch
RaySearch Laboratories is a medical technology company that develops advanced
software solutions for improved radiation therapy of cancer. RaySearch’s
products are mainly sold through license agreements with leading partners such
as Philips, Nucletron, IBA, Varian, Accuray and Brainlab. To date, 15 products
have been launched through partners and RaySearch’s software is used at over
2,000 clinics in more than 30 countries. In addition, RaySearch offers the
proprietary treatment planning system RayStation® directly to clinics. RaySearch
was founded in 2000 as a spin-off from Karolinska Institutet in Stockholm and
the company is listed in the Small Cap segment on NASDAQ OMX Stockholm.

For more information about RaySearch, visit www.raysearchlabs.com

For further information, please contact:
Johan Löf, President and CEO, RaySearch Laboratories AB
Telephone: +46 (0)8-545 061 30
johan.lof@raysearchlabs.com